Charles Schwab Investment Management Inc Surmodics Inc Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Surmodics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 111,592 shares of SRDX stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,592
Previous 110,493
0.99%
Holding current value
$4.69 Million
Previous $4.02 Million
18.48%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding SRDX
# of Institutions
111Shares Held
12.6MCall Options Held
200Put Options Held
4.7K-
Trigran Investments, Inc.2.36MShares$99.1 Million6.71% of portfolio
-
Black Rock Inc. New York, NY1.05MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA865KShares$36.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY854KShares$35.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$33.7 Million1.92% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $589M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...